Skip to content

SVCC SVCC Issuance of warrants

Issuance of warrants at other companies

Oruka Therapeutics, Inc. logo
Oruka Therapeutics, Inc.ORKA
$2.52M-75.7%
Ispire Technology Inc. logo
Ispire Technology Inc.ISPR
$91.49K
SVC
Stellar V Capital Corp. Class A Ordinary SharesSVCC
$1.22M
Evommune
 logo
Evommune EVMN
$150
CO2 Energy Transition Corp. Common Stock logo
CO2 Energy Transition Corp. Common StockNOEM
$51.75K
ADMA Biologics logo
ADMA BiologicsADMA
$1.4M

Other financials

Income statement

See full
Operating income-$183.2K+10.4%
Net income$1.2M+22.4%

Balance sheet

See full
Cash & equivalents$181.4K-70.7%
Total equity-$5.1M-12.5%
Total assets$158.4M+3.6%

Cash flow

See full
Operating cash flow-$172.7K+44.9%

Valuation

See full
Market cap$228.04M+3.5%
P/E41.3×

Returns & leverage

See full
Return on equity-114.6%
Current ratio2.2×-3.2×

Where this comes from

Reported directly by SVCC in its filing.

Tagged under the XBRL concept us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued.

The official record: SVCC’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about SVCC's issuance of warrants.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SVCC's issuance of warrants?
SVCC (SVCC) reported issuance of warrants of $1.22M in Q1 2025.
What does issuance of warrants mean?
Reflects the accounting adjustments made to additional paid-in capital specifically related to the issuance of warrants. This captures the equity component of derivative instruments issued to investors or service providers. It is a vital metric for understanding the impact of complex equity structures on shareholder value.